Joint Commission Online - April 6, 2022
Joint Commission Online is The Joint Commission's weekly newsletter and is posted every Wednesday.
April 06, 2022
The Joint Commission is revising seven elements of performance (EPs) to align with the U.S. Centers for Medicare and Medicaid Services’ (CMS) final rule that was published in the Federal Register in November 2021.
Effective immediately, the requirements applicable to home health agencies that elect The Joint Commission’s deemed status option are being revised to:
- Address comprehensive assessment completion, supervisory visits for aides, and assessment and retraining of aides.
- Human Resources (HR) standard HR.01.03.01, EPs 15, 27, and 30
- Provision of Care, Treatment, and Services (PC) standards PC.01.02.05, EPs 3 and 5, and PC.04.01.01, EP 30
- Include “allowed practitioner” in the list of individuals who can establish and update care plans.
- PC.02.01.05, EP 11
View the prepublication standards. Questions may be directed to the Department of Standards and Survey Methods.
April 06, 2022
On April 4, the U.S. Food and Drug Administration (FDA) issued a letter to healthcare providers to make them aware of a voluntary recall initiated by manufacturer KARL STORZ for certain urological endoscopes.
“As the FDA continues to evaluate the risk of patient infections and contamination issues associated with reprocessed urological endoscopes, the FDA is aware that the current reprocessing instructions for certain urological endoscopes manufactured by KARL STORZ are inadequate and are being updated by KARL STORZ,” the letter reads. “The affected urological endoscopes include cystoscopes, ureteroscopes, cystourethroscopes and ureterorenoscopes, used for viewing and accessing the urinary tract.”
The letter further states that on April 1, KARL STORTZ initiated the recall and issued an urgent field safety notice “to instruct users to discontinue all high-level disinfection methods for all affected urological endoscopes and discontinue liquid chemical sterilization for most of the affected urological endoscopes.”
“The affected urological endoscopes should be sterilized after each use by an appropriate sterilization method recommended in the instructions for use,” the letter reads.
Read the FDA letter to see its recommendations regarding this issue.
April 06, 2022
A new book from Joint Commission Resources (JCR) takes a close look at The Joint Commission’s standards and elements of performance (EPs) related to treatment planning in
The book specifically examines the Care, Treatment, and Services (CTS) chapter of the and explores the processes and activities that go into effective treatment planning within BHC programs and settings.
To help accredited BHC organizations identify and improve compliance in areas related to treatment planning, “ highlights requirements that many organizations find challenging (as seen by Joint Commission surveyors) and offers solutions and strategies for improvement.
Recent data from The Joint Commission show that on surveys conducted in BHC settings in 2020, the rate of noncompliance with standard CTS.03.01.03 was 61.69%. This requirement states, “The organization has a plan for care, treatment, or services that reflects the assessed needs, strengths, preferences, and goals of the individual served.”
Joint Commission surveyors reported the following common problems:
- Care, treatment, or service goals did not reflect the individual’s own words.
- Care, treatment, or service goals were not reviewed at specific time frames as required.
- Care, treatment, or service goals were not measurable and did not or could not show progress toward meeting identified goals.
- The treatment plan did not address all the needs and problems identified during screening and assessment.
- The treatment plan was not individualized.
- Goals and objectives in multiple plans for multiple individuals were the same, selected from scripted language found in the electronic medical record.
- Individuals were not involved in decision making for treatment planning.
- Organizations failed to follow the written plan for care, treatment, or services.
The book looks at these compliance challenges and identifies and explains ways that organizations can improve in areas such as:
- Entry to care, treatment, or services.
- Screening, assessment, and reassessment.
- Planning and development of care, treatment, or services.
- Delivery of individualized care, treatment, or services.
- Monitoring outcomes of care, treatment, or services to achieve individualized goals.
- Continuity of care, treatment, or services.
- Discharge planning.
- Prevention and wellness promotion services, when applicable.
Purchase the book.